Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | JAK2 | O60674 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1397167 | 0.86 | LMNA (0.45) | GAAMAPTJAK2LMNATSHR | |
| SCHEMBL10884904 | 0.81 | GAA (0.52) | GAAMAPTJAK2LMNAAPP | |
| Zinc Ion SCHEMBL2488066 | 0.81 | GAA (0.52) | GAAMAPTJAK2LMNAAPP | |
| Potassium Ion SCHEMBL21242 | 0.81 | GAA (0.52) | GAAMAPTJAK2LMNAAPP | |
| Water SCHEMBL4072824 | 0.79 | GAA (0.50) | GAAMAPTJAK2LMNAAPP | |
| SCHEMBL11342920 | 0.78 | ALDH1A1 (0.52) | GAAMAPTLMNAAPPSMN1; SMN2 | |
| SCHEMBL3944429 | 0.78 | HPGD (0.50) | GAAMAPTSMN1; SMN2TSHRTP53 | |
| SCHEMBL11584854 | 0.78 | GRM4 (0.46) | GAAMAPTLMNASMN1; SMN2HPGD | |
| 1-Hydroxy-2-Ethoxybenzene SCHEMBL28239263 | 0.78 | GAA (0.53) | GAAMAPTJAK2LMNAAPP | |
| SCHEMBL5583798 | 0.78 | GAA (0.44) | GAAMAPTJAK2LMNAAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727510-A2 | WOUND CARE AND METHOD FOR PREVENTING WOUND INFECTION | Epien Medical Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| WO-2025235586-A1 | DENTINAL HYPERSENSITIVITY TREATMENT | EPIEN MEDICAL, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| CN-119302921-A | Controlled release tablet of guaifenesin and preparation method thereof | 九华华源药业(桂林)有限公司 | 2025-01-14 | — | — | CN | claimed |
| US-20250000828-A1 | WOUND CARE AND METHOD FOR PREVENTING WOUND INFECTION | EPIEN MEDICAL, INC. | 2025-01-02 | — | — | US | claimed |
| WO-2025006188-A2 | WOUND CARE AND METHOD FOR PREVENTING WOUND INFECTION | EPIEN MEDICAL, INC. (US) | 2025-01-02 | — | — | WO | claimed |
| CN-119212681-A | Method for preparing 3-D printed pharmaceutical products | 百时美施贵宝公司 | 2024-12-27 | — | — | CN | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-1251874-B1 | STABILISED PHARMACEUTICAL COMPOSITIONS AND PROCESS FOR THEIR PREPARATION COMPRISING AN ANTIBIOTIC AND AN EXPECTORANT | NEW PHARMA RES SWEDEN AB (SE) | 2005-10-05 | — | — | EP | claimed |
| US-20040234490-A1 | Method for exfoliating skin | EPIEN MEDICAL, INC. | 2004-11-25 | — | — | US | claimed |
| WO-2004062580-A2 | ODORLESS FORMULATION FOR TREATING MUCOSAL DISCONTINUITIES | EPIEN MEDICAL, INC (US) | 2004-07-29 | — | — | WO | claimed |
| US-20040132810-A1 | Odorless formulation for treating mucosal discontinuities | EPIEN MEDICAL, INC. | 2004-07-08 | — | — | US | claimed |
| US-5858645-A | GENERATING PEROXIDE IN COURSE OF ASSAY BY ADDING AQUEOUS SOLUTION TO ADDUCT OF HYDROGEN PEROXIDE AND SPECIFIED ACID IN DRY STATE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | claimed |
| EP-0272778-A2 | Cyclopentyl ethers and their use in medicine | GLAXO GROUP LIMITED (GB) | 1988-06-29 | — | — | EP | claimed |
| EP-0271713-A2 | Method for preparing aqueous solutions containing chromogenic materials | SAVYON DIAGNOSTICS LTD. (IL) | 1988-06-22 | — | — | EP | claimed |
| US-4725553-A | POTASSIUM GUAIACOLSULFONATE AND POTASSIUM MONOPERSULFONATE COMPOUND; WATER SOLUBLE | HELENA LABORATORIES CORPORATION (US) | 1988-02-16 | — | — | US | claimed |
| EP-0253548-A2 | Method for the determination of occult blood and chemical compositions therefor | SAVYON DIAGNOSTICS LTD. (IL) | 1988-01-20 | — | — | EP | claimed |
| US-4541987-A | GASTROINTESTINAL CANCER, REDOX SYSTEM | HELENA LABORATORIES CORPORATION (US) | 1985-09-17 | — | — | US | claimed |